Search Results 2871-2880 of 19781 for celiac disease

1. Intra-patient Dose Escalation Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in Patients with Dumping Syndrome - Mayo Clinic

   Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

2. A Study of the Safety, Tolerability and Effectiveness of Eleclazine on Shortening the QT Interval in Adults with Long QT-3 Syndrome - Mayo Clinic

   Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

3. Study to Evaluate the Safety and Effectiveness of Localizing Biopsy-Proven Metastatic Axillary Lymph Nodes in Women with Breast Cancer Using Magseed Markers as an Alternative to the Current Practice of Placing Radioactive Seed Markers - Mayo Clinic

   Study to Evaluate the Safety and Effectiveness of Localizing Biopsy-Proven Metastatic Axillary Lymph Nodes in Women with Breast Cancer Using Magseed Markers ...

4. A Study to Collect Health Related Data and Biological Samples that will Enable Researchers to Understand the Cause of Cryptogenic New-onset Refractory Status Epilepticus - Mayo Clinic

   Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

5. A Study of Oral LGH447 in Patients with Relapsed and/or Refractory Multiple Myeloma - Mayo Clinic

   Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

6. Ablation therapy - Doctors & Departments - Mayo Clinic

   ... Celiac plexus block, Trigger point injection ... disease, Dysphagia, Esophageal cancer, Barrett's ... Experimental and Clinical Endocrinology and Diabetes.

7. Publications - Luke T. Hafdahl, M.D. - Mayo Clinic

   Ketamine for treatment of refractory depression and suicidality at the end of life. Minnesota Medicine. 2018; November/December:4-5. Schoonover KL, Lapid MI, ...

8. A Study to Assess the Antitumor Activity and Safety of IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine (Nab-P + GEM) as First Line Treatment in Subjects With Claudin 18.2 Positive, Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

   This study will also evaluate other anti-tumor effects, tumor markers and pharmacokinetics (PK) of zolbetuximab, Nab-P and GEM. Participation eligibility.

9. A Study to Evaluate Pembrolizumab, Ixazomib Citrate, and Dexamethasone to Treat Participants with Relapsed Multiple Myeloma - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

10. Fibromyalgia - Doctors and departments - Mayo Clinic

    This complicated disorder amplifies painful sensations by affecting the way your brain processes pain signals. Medications, therapy and exercise can help.